Cargando…

Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases

Detalles Bibliográficos
Autores principales: Brumfiel, Caitlin M., Saardi, Karl M., Ronkainen, Sanna D., Shenoy, Aarthi G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452245/
https://www.ncbi.nlm.nih.gov/pubmed/32875042
http://dx.doi.org/10.1016/j.jdcr.2020.07.005
_version_ 1783575131761672192
author Brumfiel, Caitlin M.
Saardi, Karl M.
Ronkainen, Sanna D.
Shenoy, Aarthi G.
author_facet Brumfiel, Caitlin M.
Saardi, Karl M.
Ronkainen, Sanna D.
Shenoy, Aarthi G.
author_sort Brumfiel, Caitlin M.
collection PubMed
description
format Online
Article
Text
id pubmed-7452245
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74522452020-08-31 Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases Brumfiel, Caitlin M. Saardi, Karl M. Ronkainen, Sanna D. Shenoy, Aarthi G. JAAD Case Rep Case Report Elsevier 2020-07-12 /pmc/articles/PMC7452245/ /pubmed/32875042 http://dx.doi.org/10.1016/j.jdcr.2020.07.005 Text en © 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Brumfiel, Caitlin M.
Saardi, Karl M.
Ronkainen, Sanna D.
Shenoy, Aarthi G.
Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
title Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
title_full Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
title_fullStr Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
title_full_unstemmed Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
title_short Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
title_sort alemtuzumab as initial therapy for sézary syndrome: a report of 2 cases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452245/
https://www.ncbi.nlm.nih.gov/pubmed/32875042
http://dx.doi.org/10.1016/j.jdcr.2020.07.005
work_keys_str_mv AT brumfielcaitlinm alemtuzumabasinitialtherapyforsezarysyndromeareportof2cases
AT saardikarlm alemtuzumabasinitialtherapyforsezarysyndromeareportof2cases
AT ronkainensannad alemtuzumabasinitialtherapyforsezarysyndromeareportof2cases
AT shenoyaarthig alemtuzumabasinitialtherapyforsezarysyndromeareportof2cases